MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5200.65M
Enterprise Value 3115.18M
Trailing P/E N/A
Forward P/E 1-3.82
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.41
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-3.64

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.29%
Return on Equity (ttm)-64.50%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.66M
Net Income Avi to Common (ttm)-31.35M
Diluted EPS (ttm)-0.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)39.63M
Total Cash Per Share (mrq)0.98
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.93
Book Value Per Share (mrq)0.87

Cash Flow Statement

Operating Cash Flow (ttm)-23.16M
Levered Free Cash Flow (ttm)-11.87M

Trading Information

Stock Price History

Beta (3Y Monthly) 4.63
52-Week Change 3-38.93%
S&P500 52-Week Change 31.08%
52 Week High 310.54
52 Week Low 32.36
50-Day Moving Average 33.36
200-Day Moving Average 35.23

Share Statistics

Avg Vol (3 month) 31.22M
Avg Vol (10 day) 3604.05k
Shares Outstanding 552.52M
Float 34.12M
% Held by Insiders 10.86%
% Held by Institutions 172.26%
Shares Short (Jan 31, 2019) 42.63M
Short Ratio (Jan 31, 2019) 43.98
Short % of Float (Jan 31, 2019) 47.00%
Short % of Shares Outstanding (Jan 31, 2019) 46.48%
Shares Short (prior month Dec 31, 2018) 42.81M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A